ClearPoint Neuro (CLPT) vs SS Innovations International (SSII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
ClearPoint Neuro (CLPT) has outperformed SS Innovations International (SSII) over the past year, losing 50.0% versus a loss of 78.7%. SS Innovations International is the larger company by market cap ($254.9 million vs $221.5 million), about 1.2 times the size. SS Innovations International converts more of its revenue into profit, with a net margin of -28.5% versus -69.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLPT | SSII |
|---|---|---|
| Share price | $6.91 | $1.27 |
| Market cap | $221.49M | $254.86M |
| 1-day change | -5.47% | -0.78% |
| YTD return | -49.49% | -77.64% |
| 1-year return | -50.00% | -78.69% |
| 5-year return | -50.04% | — |
| EPS (TTM) | $-1.21 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $36.97M | $42.48M |
| Revenue growth (YoY) | +17.78% | +105.74% |
| Net income (latest FY) | $-25.54M | $-12.13M |
| Gross margin | 61.38% | 46.00% |
| Operating margin | -65.36% | -19.29% |
| Net margin | -69.08% | -28.55% |
| 52-week high | $19.63 | $6.79 |
| 52-week low | $6.85 | $1.12 |
| Distance from 52-week high | -64.80% | -81.30% |
| Analyst consensus | none | none |
| Avg. price target upside | +211.14% | +451.18% |
| Average volume | 701.64K | 86.18K |
| Shares outstanding | 32.05M | 200.68M |
| Employees | 172 | 483 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CLPT has outperformed SSII by 28.7 percentage points over the past year.
- SS Innovations International is more profitable, keeping -28.5 cents of every revenue dollar as net income versus -69.1 cents for ClearPoint Neuro.
- SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs +17.78%).
About ClearPoint Neuro
CLPT stock →ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Health Care · Medical/Dental Instruments · 172 employees
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Health Care · Medical/Dental Instruments · 483 employees
CLPT vs SSII FAQ
Which is bigger, ClearPoint Neuro or SS Innovations International?
SS Innovations International (SSII) is larger, with a market capitalization of $254.86M compared with $221.49M for ClearPoint Neuro (CLPT).
Which stock has performed better over the past year, CLPT or SSII?
CLPT returned -50.00% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.
Are ClearPoint Neuro and SS Innovations International in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.